Lege Artis Medicinae

[Empirical versus preemptive antifungal therapy of invasive fungal infections in patients with oncohaematological diseases]

RÓKUSZ László

SEPTEMBER 20, 2011

Lege Artis Medicinae - 2011;21(08-09)

[Fungal infections present a significant problem among immunocompromised patients. The essence of empirical antifungal therapy is to collect data, physical signs and symptoms that confirm the clinically suspected invasive fungal infections and enable initiation of antifungal therapy. With the improvement of early diagnosis of invasive fungal infactions, the diagnosisdrived application of antifungal preparations has been re-evaluated. However, no consensus exists to date regarding preemptive antifungal therapy. After evaluating the benefits and potential side effects of the therapy, the relevant centers decide whether the preemptive or the empirical method should be preferred.]

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[Apoplexia in medulla oblongata]

KRUTSAY Miklós, HALUSZ Irma

Lege Artis Medicinae

[Novelties in the diagnosis and management of chronic hepatitis C]

NEMESÁNSZKY Elemér

Lege Artis Medicinae

[A Charismatic Surgeon from Várad – Remembering Zoltán Krisár ]

KOTSIS Lajos

Lege Artis Medicinae

[Manual and motion therapy of low back pain]

ORMOS Gábor, MÉSZÁROS Angéla, WEINBERGER Éva

Lege Artis Medicinae

[The Beloved Favourite of Salons – The Life of Franz Liszt ]

KÖVES Péter

All articles in the issue

Related contents

Lege Artis Medicinae

[Increasing importance of invasive fungal diseases]

PRINZ Gyula, SINKÓ János

[INTRODUCTION - Invasive mycoses are life-threatening fungal infections affecting patients with severe underlying conditions or impaired immune system. According to epidemiological studies, the incidence of invasive mycosis is increasing in several patient groups. CASE REPORT - In patients who require ICU care, the majority of invasive mycoses are caused by Candida species. A shift has been observed within the spectrum of pathogenic species. In patients undergoing chemotherapy for acute leukemia and in recipients of allogenic stem cell transplantation, however, an increased morbidity and mortality of invasive aspergillosis have been observed. The authors discuss current issues regarding the diagnosis and treatment of invasive fungal diseases on the basis of case reports. CONCLUSION - Invasive mycoses are lifethreatening infections affecting patients with severe underlying conditions. While the opportunities of state-of-the-art medicine are expanding, the incidence and significance of these infections increases. If detected and treated in time with appropriate antifungal agents, these infections can be efficiently treated.]

Lege Artis Medicinae

[Treatment of invasive fungal infections: present and future]

SINKÓ János

[In immunocompromised patients morbidity and mortality caused by invasive fungal infections is increasing. It is difficult to establish early diagnosis of mycosis by laboratory tests currently available. Antifungal drugs are often toxic, their spectrum of action is limited and their cost is substantial. In the search for alternative therapeutic modalities, antifungal compounds were synthesised against several targets of the fungal cell. At present, the following drugs have almost completed drug registration procedures: voriconazole, posaconazole and ravuconazole from the new azol group, a candin named caspofungin, and the polyene liposomal nystatin. Nikkomycin Z, sordarins and some other compounds are also seem to be promising. In addition to new antifungal drugs, substantial improvement in the outcome of invasive fungal infections requires extended diagnostic capabilities, as well as a reappraisal of our principles of prophylaxis and treatment.]

Hypertension and nephrology

[About the care of patients with hyperuricaemia and gout]

[This consensus document is intended to provide guidance for the effective and efficient treatment of asymptomatic individuals with high uric acid levels and gout patients.]